Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688076 Jiangsu Sinopep-Allsino Biopharmaceutical
- 54.59
- +1.44+2.71%
Market Closed Apr 24 15:00 CST
12.26BMarket Cap24.98P/E (TTM)
55.18High53.08Low56.23KlotVolume53.22Open53.15Pre Close305.99MTurnover2.50%Turnover Ratio30.33P/E (Static)224.60MShares81.5052wk High4.37P/B12.26BFloat Cap41.8052wk Low63.78Limit Up224.60MShs Float92.45Historical High42.52Limit Down3.95%Amplitude17.39Historical Low0.50Dividend TTM54.42Avg Price26.32KlotAsk0.92%Div YieldTTM100Lot Size25.88KlotBid
About Jiangsu Sinopep-Allsino Biopharmaceutical Company
The company actively carries out product development and business expansion in various fields, from advanced pharmaceutical intermediates, APIs to formulations, and is deeply involved in segmented fields, focusing on the peptide business, and forming a two-wheel drive development pattern for independently selected products and customized products. The company is a biomedical enterprise that focuses on polypeptide drugs and small molecule chemicals, strategically lays out the oligonucleotide business, and combines independent research and development with customized R&D and production. The company's main products are self-selected products, customized products and technical services.
Company Profile
Short Name-A诺泰生物
Company NameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Listing DateMay 20, 2021
Issue Price15.57
Shares Offered53.30M share(s)
FoundedApr 3, 2009
Chairmanziquan tong
Legal Representativeziquan tong
General Managerziquan tong
Secretaryhua zhou
Employees2028
ProvinceJiang Su Sheng
Phone0571-86297893
Office AddressRoom 1201, Block E, Hangzhou Normal University Science Park, No. 1378 Wenyi West Road, Yuhang District, Hangzhou
Zip Code311121
Registered AddressNo. 28 Linpu Road, Lianyungang Economic and Technological Development Zone, Jiangsu
Fax0571-86298631
Emailir@sinopep.com
Websitehttp://www.sinopep.com/
Business License913207006871974358
BusinessProduction of freeze-dried powder injections, small-volume injections (including non-final sterilization), raw materials, tablets, hard capsules, health products, and medical devices (all operated according to license approval); research and development of pharmaceutical technology and biotechnology; production of pharmaceutical intermediates and polypeptide intermediates (excluding products involving special approval, such as pharmaceuticals, health products, food, feed, etc.); production and sale of fine chemical products (excluding hazardous chemicals); import and export business of various kinds of commodities and technologies operated by state-limited companies, with the exception of goods and technologies operated by state-restricted companies or prohibited from being imported. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)
Company Executives
- Name
- Position
- Salary
- yan jiang
- Directors
- 150.00K
- guoqiang shi
- Directors, Deputy General Manager, Core Technical Personnel, Deputy Director of the Research Institute
- 3.01M
- yuming pan
- Directors
- --
- ziquan tong
- Directors, Core Technical Personnel
- 2.63M
- dezhong zhao
- Directors
- --
- deyi zhao
- Directors
- 600.60K
- fuqiang jin
- Directors, Core Technical Personnel, Director of the Research Institute
- 1.80M
- qiangguo xu
- Independent Directors
- 119.00K
- feng qu
- Independent Directors
- 119.00K
- wenyan hu
- Independent Directors
- 119.00K
- jifu gao
- Independent Directors
- 119.00K
- hua zhou
- Board Secretary
- 973.70K
- leer wu
- Securities Affairs Representative
- --
- xiping qin
- Auditors
- 119.00K
- jianjun jiang
- Deputy General Manager, Core Technical Personnel, Deputy Director of the Research Institute
- 885.50K
- tangqing li
- Deputy General Manager
- 1.55M
- xiaohua li
- Deputy General Manager
- 1.54M
- wei ding
- Chief Financial Officer
- 984.20K
- ting liu
- Core Technical Personnel
- 642.40K
- yu zhang
- Core Technical Personnel
- 482.00K
- hao lin
- Core Technical Personnel
- 1.05M
- chengqing zhao
- Core Technical Personnel
- 1.08M
- meilu sun
- Employee Supervisors
- 472.30K
- fangfei qi
- Employee Supervisors
- 112.60K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs